Phosphoglycerate kinase 1 silencing by a novel microRNA microRNA-4523 protects human osteoblasts from dexamethasone

Jin-Qian Liang1, Zhen-Tao Zhou2, Lin Bo3

  • 1Department of Orthopaedics, Peking Union Medical College Hospital, Beijing, China.

Cell Death & Disease
|October 20, 2021
PubMed

Insights

MicroRNA-4523 (miR-4523) protects human osteoblasts from dexamethasone (DEX) by targeting phosphoglycerate kinase 1 (PGK1). This activates the Nrf2 pathway, reducing oxidative stress and cell death, offering a novel therapeutic strategy.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Dexamethasone (DEX) induces oxidative injury and apoptosis in human osteoblasts.
  • Nuclear-factor-E2-related factor 2 (Nrf2) activation can protect against DEX-induced damage.
  • Phosphoglycerate kinase 1 (PGK1) depletion activates Nrf2 signaling.

Purpose of the Study:

  • To identify and characterize a novel microRNA targeting PGK1.
  • To investigate the role of this microRNA in activating the Nrf2 cascade.
  • To determine if this microRNA can protect osteoblasts from DEX-induced injury.

Main Methods:

  • RNA fluorescent in situ hybridization, RNA pull-down, and Argonaute-2 RNA immunoprecipitation to confirm miR-4523 and PGK1 interaction.
  • Lentiviral constructs for miR-4523 overexpression and PGK1 knockout (CRISPR/Cas9).
  • Assessment of Nrf2 signaling activation, gene expression (NQO1, GCLC, HO1), reactive oxygen species production, and cell apoptosis.

Main Results:

  • MicroRNA-4523 (miR-4523) directly binds to PGK1 mRNA, downregulating PGK1 expression in osteoblasts.
  • miR-4523 overexpression activates the Nrf2 cascade by promoting Keap1-Nrf2 disassociation and Nrf2 nuclear translocation.
  • miR-4523 significantly attenuates DEX-induced oxidative stress, injury, and apoptosis, an effect dependent on Nrf2 and PGK1.
  • miR-4523 is downregulated in human osteonecrosis tissues from DEX-treated patients.

Conclusions:

  • PGK1 silencing by miR-4523 protects human osteoblasts against DEX-induced damage via Nrf2 pathway activation.
  • miR-4523 represents a potential therapeutic target for preventing DEX-induced osteotoxicity.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K